Germany's Bayer acquires BlueRock for $600M

Source: Dukascopy Bank SA
Germany's drugmaker Bayer is planning to take full control over BlueRock Therapeutics, the cell therapy developer, in a deal worth $600M. as it seeks to resume to the company's drug development pipeline.
Back to articles

Actual Topics

Thu, 08 Aug 2019 14:13:12 GMT

Turkey to prevent delay of safe zone agreement

On Thursday, Mevlut Cavusoglu, the Turkish Foreign Minister, stated the country would prevent the delay of the safe zone pact, agreed in cooperation with the United States, adding that this agreement should not suffer the same fate as the accord on Syrian's Manbij.

Thu, 08 Aug 2019 11:01:58 GMT

Siemens Healthineers to take over USs Corindus

Germany's Siemens Healthineers is set to acquire US firm Corindus Vascular Robotics in a deal worth $1.1B, the largest acquisition Siemens division launch an IPO on the stock market.

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.